Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation

Dabrafenib and trametinib therapy for BRAF V600E‐mutant non‐small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical practice. However, the efficacy and safety of this combination therapy in elderly patients remain unclear....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Dotsu, Yosuke, Fukuda, Minoru, Honda, Noritaka, Gyotoku, Hiroshi, Kohno, Yoshihisa, Suyama, Takayuki, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Miyazaki, Taiga, Sakamoto, Noriho, Obase, Yasushi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2020
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812073/
https://ncbi.nlm.nih.gov/pubmed/33215864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13756
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky